Comparison of PAC and MOAH for understanding the carcinogenic and developmental toxicity potential of mineral oils.


Journal

Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295
Titre abrégé: Regul Toxicol Pharmacol
Pays: Netherlands
ID NLM: 8214983

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 26 11 2021
revised: 31 03 2022
accepted: 19 05 2022
pubmed: 27 5 2022
medline: 15 6 2022
entrez: 26 5 2022
Statut: ppublish

Résumé

The carcinogenicity and developmental toxicity of unrefined mineral oil is related to its 3-7 ring polycyclic aromatic compounds (PAC) content. Therefore, refining operations focus on the targeted removal PAC from mineral oil that may contain aromatics of low toxicological concern. There are thus, two types of aromatic substances in mineral oil: hazardous and non-hazardous. The first type consists of 3-7 ring PAC which may be naked (unsubstituted) or lowly alkylated. The second type or non-hazardous consists of 1-7 ring aromatics with high degree of alkylation or lack of bay or fjord regions. Although these are toxicologically different, they may both elute in the same fraction when using chromatography. To understand how these two aromatic types are related we have assessed the entire mineral oil refinement process by measuring total mineral oil aromatic hydrocarbons (MOAH) content by chromatography next to regulatory hazard tests which focus on 3-7 ring PAC. MOAH content is positively correlated to its molecular weight resulting in aromatic content bias for high viscosity substances. Hazard to 3-7 ring PAC is best controlled by the validated IP346 or modified Ames test. We explain the concept of high vs low alkylation by shortly reviewing new data on alkylated PAC.

Identifiants

pubmed: 35618173
pii: S0273-2300(22)00080-0
doi: 10.1016/j.yrtph.2022.105193
pii:
doi:

Substances chimiques

Carcinogens 0
Hydrocarbons, Aromatic 0
Minerals 0
Oils 0
Polycyclic Compounds 0
Mineral Oil 8020-83-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105193

Informations de copyright

Copyright © 2022 CONCAWE, Boulevard du Souverain 165, B-1160 Brussels, Belgium. Published by Elsevier Inc. All rights reserved.

Auteurs

Juan-Carlos Carrillo (JC)

Shell Global Solutions International B.V., PO Box 162, 2501 AN, The Hague, the Netherlands; CONCAWE, Boulevard Du Souverain 165, Mineral Hydrocarbons Task Force, B-1160, Brussels, Belgium. Electronic address: juan-carlos.carrillo@shell.com.

Lenny Kamelia (L)

Shell Global Solutions International B.V., PO Box 162, 2501 AN, The Hague, the Netherlands; CONCAWE, Boulevard Du Souverain 165, Mineral Hydrocarbons Task Force, B-1160, Brussels, Belgium.

Julija Romanuka (J)

Shell Global Solutions International B.V., PO Box 162, 2501 AN, The Hague, the Netherlands.

Olaf Kral (O)

Shell Deutschland Oil GmbH, Suhrenkamp 71-77, 22284, Hamburg, Germany.

Allison Isola (A)

ExxonMobil Biomedical Sciences, Inc, 1545 US Highway 22 East Annandale, NJ, 08801-3059, USA; CONCAWE, Boulevard Du Souverain 165, Mineral Hydrocarbons Task Force, B-1160, Brussels, Belgium.

Helena Niemelä (H)

CONCAWE, Boulevard Du Souverain 165, Mineral Hydrocarbons Task Force, B-1160, Brussels, Belgium. Electronic address: helena.niemela@concawe.eu.

Anna Steneholm (A)

CONCAWE, Boulevard Du Souverain 165, Mineral Hydrocarbons Task Force, B-1160, Brussels, Belgium; Nynas AB, P.O. Box 10 700, SE-121 29, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH